Michael Holloway
Vorstandsvorsitzender bei GMH Tequesta Holdings LLC
Aktive Positionen von Michael Holloway
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Life360 Innovations, Inc.
 Life360 Innovations, Inc. Medical SpecialtiesHealth Technology Life360 Innovations, Inc. is a Canadian private company that manufactures and distributes licensed medical devices and products related to urology through a proprietary partner network. The company is based in Vancouver, Canada. The company is currently recruiting Canadian subjects and clinical urology sites for a post-market clinical follow-up study for their product, Continuo®. The CEO of the company is Robert Orr. | Direktor/Vorstandsmitglied | - | - |
GMH Tequesta Holdings LLC
 GMH Tequesta Holdings LLC Medical/Nursing ServicesHealth Services GMH Tequesta Holdings LLC provides healthcare services. The private company is based in Tequesta, FL. The CEO of the company is Michael Holloway. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Michael Holloway
Statistik
International
| Vereinigte Staaten | 2 |
| Kanada | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
GMH Tequesta Holdings LLC
GMH Tequesta Holdings LLC Medical/Nursing ServicesHealth Services GMH Tequesta Holdings LLC provides healthcare services. The private company is based in Tequesta, FL. The CEO of the company is Michael Holloway. | Health Services |
Life360 Innovations, Inc.
Life360 Innovations, Inc. Medical SpecialtiesHealth Technology Life360 Innovations, Inc. is a Canadian private company that manufactures and distributes licensed medical devices and products related to urology through a proprietary partner network. The company is based in Vancouver, Canada. The company is currently recruiting Canadian subjects and clinical urology sites for a post-market clinical follow-up study for their product, Continuo®. The CEO of the company is Robert Orr. | Health Technology |
- Börse
- Insiders
- Michael Holloway
- Erfahrung
